Affiliation:
1. Central Facility of Instrumentation, School of Pharmaceutical Sciences, IFTM University, Moradabad-244001, India
Abstract
Objective:
Aripiprazole, a synthetic compound, obtained by chemical modification of the
structure of quinolinone is considered as an atypical antipsychotic drug. The present review is an attempt
to summarize the updated information related to reported chemistry and pharmacology of Aripiprazole.
Development:
Aripiprazole, under development by Otsuka Pharmaceutical, was approved by the U.S.
Food and Drug Administration (USFDA) by the end of 2002 with an aim to treat patients with schizophrenia.
This drug got approved by European Commission in February 2013 to treat the patients having
severe manic episodes in bipolar I disorder Additionally, it got approval in Japan in January 2006 and in
Canada in 2014.
Pharmacology:
Aripiprazole shows high specificity for dopamine receptor especially D2 and D3, serotonin
5-HT1A and serotonin 5-HT2A receptors, reasonable specificity for dopamine D4, serotonin 5-
HT2C and 5-HT7, alpha1-adrenergic and histamine H1 receptors. It also shows moderate specificity for
the serotonin reuptake. The major side effects include headache, agitation, akithesia, anxiety, tachycardia,
insomnia, postural hypotension, constipation, vomiting, dizziness, nervousness and somnolence.
Conclusion:
The present article embarks the available information on Aripiprazole with emphasis on its
clinical pharmacology, mechanism of action, pharmacokinetics, pharmacodynamics, metabolism and
clinical trials.
Publisher
Bentham Science Publishers Ltd.
Reference46 articles.
1. Krivoy A.; Fischel T.; Weizman A.; [The cognitive deficit in schizophrenia]. Harefuah 2012,151(5),277-280, 319
2. Patel K.R.; Cherian J.; Gohil K.; Atkinson D.; Schizophrenia: overview and treatment options. P 2014,39(9),638-645
3. Lewis D.A.; Lieberman J.A.; Catching up on schizophrenia: natural history and neurobiology. Neuron 2000,28(2),325-334
4. Diagnostic and Statistical Manual of Mental Disorders 2000,297-343
5. Schultz S.H.; North S.W.; Shields C.G.; Schizophrenia: a review. Am Fam Physician 2007,75(12),1821-1829
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献